Sivik Global Healthcare LLC Boosts Stock Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Sivik Global Healthcare LLC boosted its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 43.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 115,000 shares of the company's stock after purchasing an additional 34,997 shares during the quarter. Acadia Healthcare comprises 3.1% of Sivik Global Healthcare LLC's portfolio, making the stock its 13th biggest holding. Sivik Global Healthcare LLC owned 0.12% of Acadia Healthcare worth $7,292,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. GAMMA Investing LLC grew its holdings in Acadia Healthcare by 57.1% during the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company's stock valued at $42,000 after buying an additional 241 shares in the last quarter. Blue Trust Inc. grew its holdings in shares of Acadia Healthcare by 86.1% in the second quarter. Blue Trust Inc. now owns 536 shares of the company's stock valued at $36,000 after purchasing an additional 248 shares in the last quarter. Commonwealth Equity Services LLC lifted its position in Acadia Healthcare by 3.5% during the second quarter. Commonwealth Equity Services LLC now owns 7,595 shares of the company's stock valued at $513,000 after purchasing an additional 257 shares during the last quarter. Atria Investments Inc grew its stake in shares of Acadia Healthcare by 4.7% in the 3rd quarter. Atria Investments Inc now owns 6,844 shares of the company's stock worth $434,000 after buying an additional 308 shares in the last quarter. Finally, KBC Group NV increased its holdings in shares of Acadia Healthcare by 14.4% in the 3rd quarter. KBC Group NV now owns 2,688 shares of the company's stock worth $170,000 after buying an additional 338 shares during the last quarter.

Acadia Healthcare Stock Down 1.2 %

Shares of ACHC stock traded down $0.47 on Thursday, hitting $39.36. The stock had a trading volume of 1,148,328 shares, compared to its average volume of 999,576. Acadia Healthcare Company, Inc. has a one year low of $39.27 and a one year high of $87.77. The business has a 50 day moving average price of $59.60 and a 200 day moving average price of $66.10. The company has a market cap of $3.66 billion, a PE ratio of 12.99, a P/E/G ratio of 1.78 and a beta of 1.33. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, topping analysts' consensus estimates of $0.90 by $0.01. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business had revenue of $815.60 million during the quarter, compared to the consensus estimate of $819.42 million. During the same period in the previous year, the company posted $0.91 earnings per share. The firm's revenue was up 8.7% on a year-over-year basis. Research analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have commented on ACHC shares. KeyCorp initiated coverage on shares of Acadia Healthcare in a research note on Friday, October 11th. They set a "sector weight" rating for the company. Barclays cut their price target on shares of Acadia Healthcare from $83.00 to $76.00 and set an "overweight" rating on the stock in a report on Monday, September 30th. StockNews.com upgraded Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Monday, November 4th. Deutsche Bank Aktiengesellschaft increased their price target on Acadia Healthcare from $70.00 to $75.00 and gave the stock a "hold" rating in a report on Friday, August 2nd. Finally, Royal Bank of Canada restated an "outperform" rating and set a $94.00 price objective on shares of Acadia Healthcare in a report on Friday, September 20th. Five investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $86.67.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.